In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an open offer for 20% shares in Zenotech, an affiliate of Ranbaxy.
In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an open offer for 20% shares in Zenotech, an affiliate of Ranbaxy.